Human Resistin FlowCytomix Simplex

Also known as: Cysteine-rich secreted protein FIZZ3, ADSF, RETN1

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS82040FF*

Cat. No. Size
BMS82040FF 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human Resistin FlowCytomix Simplex.

Click on image to view more information.

  • Data for Human Resistin FlowCytomix Simplex.
Description

Description: This FlowCytomix Simplex Kit is designed for the measurement of Human Resistin in an immunoassay analyzed on a flow cytometer. Together with the FlowCytomix Human Basic Kit (cat. BMS8420FF), this kit can be used to detect Resistin alone or can be multiplexed with other Simplex Kits to measure a variety of analytes.

This kit contains bead population B4.

Resistin is a hormone secreted by adipose tissue. The length of the resistin pre-peptide in human is 108 aminoacids; the molecular weight is ~12.5 kDa. Resistin was originally found to be produced and released from adipose tissue to serve endocrine functions likely involved in insulin resistance. This idea primarily stems from studies demonstrating that serum resistin levels increase with obesity in several model systems. Since these observations, further research has linked resistin to other physiological systems such as inflammation and energy homeostasis. Current research is proposing to link resistin to inflammation and energy homeostasis, including its alleged role in insulin resistance in obese subjects.

Details
Reactivity Human
Sample Volume 25 uL
Suitable Sample Types cell culture supernatant, serum, plasma (citrate)
Sensitivity 1.7 pg/mL
Standard Curve Range 55 - 40,000 pg/mL
Components 1 vial (175 ul) Fluorescent Beads (20x) coated with polyclonal antibody to human Resistin, Bead Population B4
2 vials human Resistin Standard (lyophilized): 800 ng/ml upon reconstitution
1 vial (350 ul) Biotin-Conjugate (20x) anti-human Resistin polyclonal antibody
Reported Applications Multiplex Immunoassay
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
References

References: Nagaya,N.; Kojima,M.; Kangawa,K.. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia. Intern.Med 2006;45:127-134. (Link)

Kao,P.C.; Shiesh,S.C.; Wu,T.J.. Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci. 2006;36:163-169. (Link)

Despres,J.P.. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. J Endocrinol Invest 2006;29:77-82. (Link)

Friedman,A.N.. Adiposity in dialysis: good or bad?. Semin.Dial. 2006;19:136-140. (Link)

Bray,G.A.; Bellanger,T.. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine. 2006;29:109-117. (Link)

McGavock,J.M.; Victor,R.G.; Unger,R.H.; Szczepaniak,L.S.. Adiposity of the heart, revisited. Ann Intern.Med 2006;144:517-524. (Link)

Das,S.K.. Body composition measurement in severe obesity. Curr.Opin.Clin Nutr Metab Care 2005;8:602-606. (Link)

Ahima,R.S.. Metabolic actions of adipocyte hormones: focus on adiponectin. Obesity (Silver.Spring) 2006;14 Suppl 1:9S-15S. (Link)

Hauguel-de,Mouzon S.; Lepercq,J.; Catalano,P.. The known and unknown of leptin in pregnancy. Am J Obstet.Gynecol. 2006;194:1537-1545. (Link)